Ortho RTi to Present Further Scientific Validation Data at the Orthopaedic Research Society’s 2019 Annual Meeting KIRKLAND, Quebec, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTi” or the “Corporation”), an emerging Orthopaedic and Sports Medicine technology...

Evidence on the Safety and Efficacy of Ortho-R in a Large Animal Model Presented at 2018 SICOT World Congress KIRKLAND, Quebec, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTi” or the “Corporation”), an emerging Orthopaedic and Sports Medicine technology...

Ortho Regenerative Technologies Inc. Appoints Accomplished Life Science Executive, Luc Mainville, as CFO KIRKLAND, Quebec, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Ortho Regenerative Technologies Inc. (“Ortho RTi” or the “Corporation”) (CSE: ORTH) today announced the appointment of Luc Mainville as Senior...

Ortho RTi Signs Agreement with a Leading CMO for the Manufacture of cGMP Finished Dosage Form Ortho-R in Preparation for Planned First-in-Human Study KIRKLAND, Quebec, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTi” or the “Corporation”), an emerging Orthopaedic and Sports Medicine Technology...

Ortho Regenerative Technologies Inc. Announces CFO Change KIRKLAND, Quebec, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTi” or the “Corporation”) announces that Benedek (Ben) Simo has been appointed Interim...